COMMENTARY: Havana Syndrome’s New Term Gives Rise to New Approaches

Havana Syndrome’s New Term Gives Rise to New Approaches by Dr. James Giordano examines the Department of Defense’s recent proposal to adopt a new nomenclature, “directed energy biological effects,” or DEBE, to define and describe biological events and effects previously associated with “anomalous health incidents” aka Havana Syndrome.

This proposal represents a formal recognition that directed energy technologies have matured from laboratory experiments into deployable military assets capable of weaponization. With this new language, the department moves away from the inherent ambiguity of previous descriptors that often fostered skepticism and impeded the development of focused diagnostic protocols. The new terminology directs scientific attention toward identifying mechanistic biomarkers and neurobiological correlates that are consistent with directed energy exposure.

The formal acknowledgment of these effects provides a necessary policy foundation for establishing dedicated research and deterrence programs. These initiatives aim to strengthen strategic resilience both before and after the deployment of directed energy systems through improved forensics and defensive capabilities. For affected personnel, this move offers validation of their clinical experiences and establishes a basis for standardized pathways of care within the Military Health System. Dr. Giordano proposes the creation of a joint center of excellence to integrate intelligence and neuroscience while accelerating the development of portable sensors and advanced shielding technologies. This strategic evolution positions the Defense Department to lead in a consequential domain of modern warfare by incorporating these threats into force protection doctrine and international governance efforts.

Become a member for $10/year to gain early access to Dr. Giordano’s exclusive pieces for SWJ.